Evidence map›Paper›PMID 32659939›Full record

ArticleInternational journal of molecular sciences2020

Green Synthesized Montmorillonite/Carrageenan/Fe

Yen Pin Yew, Kamyar Shameli, Shaza Eva Mohamad, Kar Xin Lee, Sin-Yeang Teow

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. FeNanomaterials (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Development of Responsive Nanoparticles for Cancer Therapy.International journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Boron and Gadolinium Loaded FeInternational journal of molecular sciences · 2021
    Article
  13. Article
  14. Review
  15. Green Synthesis of FeInternational journal of nanomedicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yen Pin YewChemical Energy Conversion and Application (ChECA), Malaysia-Japan International Institute of Technology (MJIIT), Universiti Teknologi Malaysia, Jalan Sultan Yahya Petra, Kuala Lumpur 54100, Malaysia.
Kamyar ShameliChemical Energy Conversion and Application (ChECA), Malaysia-Japan International Institute of Technology (MJIIT), Universiti Teknologi Malaysia, Jalan Sultan Yahya Petra, Kuala Lumpur 54100, Malaysia.ORCID 0000-0002-3955-4604
Shaza Eva MohamadChemical Energy Conversion and Application (ChECA), Malaysia-Japan International Institute of Technology (MJIIT), Universiti Teknologi Malaysia, Jalan Sultan Yahya Petra, Kuala Lumpur 54100, Malaysia.
Kar Xin LeeChemical Energy Conversion and Application (ChECA), Malaysia-Japan International Institute of Technology (MJIIT), Universiti Teknologi Malaysia, Jalan Sultan Yahya Petra, Kuala Lumpur 54100, Malaysia.
Sin-Yeang TeowDepartment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Jalan, Universiti, Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia.ORCID 0000-0002-3824-0224
University of Technology Malaysia · MYSunway University · MY

Funding

Malaysia Ministry of Higher Education Tier 1 grant #17H60Malaysia Ministry of Higher Education Tier 1 grant #20H33Malaysia Ministry of Higher Education Tier 1 grant #20H55
6 · The paper itself

Abstract

Discovery of a novel anticancer drug delivery agent is important to replace conventional cancer therapies which are often accompanied by undesired side effects. This study demonstrated the synthesis of superparamagnetic magnetite nanocomposites (Fe

Indexed as

Antineoplastic AgentsBentoniteCarrageenanCell Line, TumorColorectal NeoplasmsDrug CarriersDrug Delivery SystemsDrug LiberationFerric CompoundsFerrosoferric OxideGreen Chemistry TechnologyHCT116 CellsHumansHydrogen-Ion ConcentrationHydroxybenzoatesMagnetite NanoparticlesAntineoplastic AgentsBentoniteCarrageenanDrug CarriersFerric Compoundsferric oxideFerrosoferric OxideHydroxybenzoatesMagnetite Nanoparticlesprotocatechuic acidanticancercarrageenandrug deliveryFe3O4 nanocompositesiron oxidemontmorilloniteprotocatechuic acid

Identifiers

PMID32659939
PMCPMC7402292
OpenAlexW3041087416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.